Key statistics
As of last trade, Janux Therapeutics Inc (JANX:NMQ) traded at 13.85, 14.27% above the 52 week low of 12.12 set on Feb 05, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.52 |
|---|---|
| High | 13.89 |
| Low | 13.34 |
| Bid | 13.84 |
| Offer | 13.90 |
| Previous close | 13.44 |
| Average volume | 779.25k |
|---|---|
| Shares outstanding | 60.83m |
| Free float | 56.62m |
| P/E (TTM) | -- |
| Market cap | 817.58m USD |
| EPS (TTM) | -1.83 USD |
Data delayed at least 15 minutes, as of Mar 04 2026 16:34 GMT.
More ▼
- Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
- Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
- Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
- Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors
- Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
More ▼
